Ginkgo Biloba Leaf P.E.

Specifications1.USP/EP/BP/FCC/CP 2.GMP/Non-GMO/KOSHER/HALAL/HACCP 3.10 Years Experience 4.Delivery within 5 days 5.OEM abilityProduct NameGinkgo biloba P.E.(GBE)Botanical SourceDried leaves of Ginkgo biloba L.Used PartLeafActive IngredientGinkgoflavon Glycosides,Total Terpene LacosidesCAS No.84650-60-2Specifications1. CP2005 (Ginkgoflavon Glycosides≥24%, Total Terpene Lacosides≥6%, Acid<10PPM,Peak area ratio 0.8-1.5)2. CP2010 (Ginkgoflavon Glycosides≥24%, Total Terpene Lacosides≥6%, Acid<5ppm, peak="" area="" ratio="" q:k="" i:q="">0.15) 3. DAB (Ginkgoflavon Glycosides 22~27%, Total Terpene Lacosides5.4~6.6%, Acid<5PPM;Ginkgolide A+B+C 2.8%-3.4%; Bilobalide 2.6%-3.2%)4. EP6 (Ginkgoflavon Glycosides 22~27%, Total Terpene Lacosides5.4~6.6%, Acid<5PPM;Ginkgolide A+B+C 2.8%-3.4%; Bilobalide 2.6%-3.3%)5. EGB761 (Ginkgoflavon Glycosides≥24%, Total Terpene Lacosides≥6%, Acid<5PPM, Peak area ratio 0.8-1.5) 6. USP31 (Ginkgoflavon Glycosides 24~27%, Total Terpene Lacosides5.4~12%,Acid<5PPM, Peak area ratio 0.8-1.5; Ginkgolide A+B+C 2.8%-6.2%; Bilobalide 2.6%-5.8%)7. Water-soluble Grade (Ginkgoflavon Glycosides≥24%, Total Terpene Lacosides≥6%, Acid 1~5PPM; sobubility:1~5%)8. Low acid (Ginkgoflavon Glycosides≥24%, Total Terpene Lacosides≥6%, Acid<1PPM) 5ppm,AssayHPLCCharacterPale yellow or light brown fine powderFunction1. Dilated blood vessels, protected vascular endothelial organizations2. Regulating blood lipids3. Protect low-density lipoprotein4. Improve blood rheology5. Inhibit PAF(platelet activating factor),the inhibition of thromboxane formation6. Scavenging free radicals7. Anti-hypoxia8. Prevention artery spasmUsageWidely used in food, health care and cosmetic fields.PackagePacked with double plastic bags directly and with an Aluminum foil bag or Drum external (25kg/Drum)Expiration2 years